Navigation Links
Curemark Opens Autism Trials at New Jersey Site

RYE, N.Y., July 28 /PRNewswire/ -- Curemark, LLC (, a drug research and development company focused on the treatment of neurological diseases, announced that Saint Peter's University Hospital in New Brunswick, New Jersey, is participating in the company's Phase III clinical trials for CM-AT, Curemark's autism treatment.  

Saint Peter's is affiliated with the Drexel University College of Medicine in Philadelphia.  Drexel University College of Medicine began enrolling patients in the CM-AT autism study earlier this year.  Curemark's clinical trial program for CM-AT now encompasses a total of 13 sites nationwide.  

CM-AT, which has received Fast Track status from the FDA, is based on Curemark's research that showed enzyme deficiencies in autistic children, resulting in an inability to digest protein.  The inability to digest protein affects the availability of amino acids, the building blocks of chemicals essential for brain function.  If approved, CM-AT will be one of the first therapies to address the underlying physiology of autism.  

"We are pleased that trial enrollment is proceeding well at Drexel University College of Medicine and that Saint Peter's is also taking part in the clinical research for CM-AT," said Joan Fallon, Curemark founder and CEO.  "We're currently assessing the viability of other possible sites around the country to join the autism study."

For information on enrolling in the Curemark CM-AT autism trials, log on to and search "Curemark."


Curemark is a drug research and development company focused on the treatment of neurological and other diseases, especially those with dysautonomic components, by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon, which revealed a lack of protein digestion in children with autism and ADHD. To learn more about our innovative science, visit

Safe Harbor Statement

This news release contains forward-looking statements that involve risks and uncertainties that could cause our actual results and experiences to differ materially from anticipated results and expectations expressed in such forward-looking statement. These forward-looking statements include, without limitation, statements regarding the mechanism of action of CM-AT, its potential advantages, its potential for use in treating autism, as well as the timing, progress and anticipated results of the clinical development and regulatory processes concerning CM-AT. These statements are based on our current beliefs and expectations as to such future outcomes, and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a material difference include, among others, risks that the results of clinical trials will not support our claims or beliefs concerning the effectiveness of CM-AT, our ability to finance our development of CM-AT, regulatory risks, and our reliance on third party researchers and other collaborators. We assume no obligation to update these statements, except as required by law.

SOURCE Curemark, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Curemark Begins Autism Trials at Two More Sites
2. Dr. Joan Fallon, Curemark CEO, Addresses Keystone Symposia Meeting On Autism
3. Curemark Adds UC Davis MIND Institute to Autism Clinical Trial Sites
4. Curemark CM-AT Autism Treatment Granted FDA Fast Track Status
5. Curemark Enrolling Patients In Phase III Autism Trials At Ten Sites
6. Curemark Opens Patient Enrollment for Autism Treatment at Three More Clinical Trial Sites
7. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
8. Curemark Announces Senior Executive Promotions
9. Curemark CEO Presents at Epigenomics Conference
10. Curemark Closes Series A Financing
11. Curemark Appoints Preeminent Pediatrics Gastroenterologist
Post Your Comments:
(Date:10/13/2015)... DUBLIN , Oct. 13 2015 /PRNewswire/ ... announced the addition of the "US ... - 16 Countries (2010-2021)" report to ... has announced the addition of the ... Repair - 16 Countries (2010-2021)" report ...
(Date:10/13/2015)... LAUDERDALE, Fla. , Oct. 13, 2015   ... developer of solutions that aid in the early detection ... has awarded Vigilant,s founder and CEO, Matthew ... the Year Award, which recognizes an entrepreneur who has ... Florida,s life sciences industry in the leadership ...
(Date:10/13/2015)... 13, 2015   Happy Vitals ®, ... home testing kit for breast milk.  The ... an unparalleled, detailed assessment of the nutrition ... carbs and key vitamins—all charted over time ... health tracking.  In addition, Happy Vitals also offers ...
Breaking Medicine Technology:
(Date:10/13/2015)... , ... October 13, 2015 , ... ProText Kinetic Panel ... . With ProText Kinetic Panel, users can create energetic text animations in any layout ... into the Final Cut Pro X timeline and stylize the text. With intuitive on-screen ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... of IBM software products, introduced a new company, RightSensor™ LLC, an Internet of ... communications capability. RightSensor™ provides a fully-managed approach for customers requiring sensor hardware ...
(Date:10/13/2015)... Hollywood, CA (PRWEB) , ... October 13, 2015 , ... ... published by Medical New Today on September 18, 2015. The research, which was conducted ... by Dr. Wael Sabbah and colleagues, show connections between stress during pregnancy and future ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... A child ... that’s why SmileCareClub , the leading remote invisible aligner system, has joined with ... would otherwise go without it. For each aligner treatment plan purchased, SmileCareClub will donate ...
(Date:10/13/2015)... Hills, CA (PRWEB) , ... October 13, 2015 ... ... management and workflow solutions, announced today their Title Sponsorship of Synergy 2015. The ... in Henderson, NV at Green Valley Ranch and will unite customers, partners, WennSoft ...
Breaking Medicine News(10 mins):